Package 71335-1514-1

Brand: buprenorphine hcl and naloxone hcl

Generic: buprenorphine and naloxone
NDC Package

Package Facts

Identity

Package NDC 71335-1514-1
Digits Only 7133515141
Product NDC 71335-1514
Description

30 TABLET in 1 BOTTLE (71335-1514-1)

Marketing

Marketing Status
Marketed Since 2020-02-17
Brand buprenorphine hcl and naloxone hcl
Generic buprenorphine and naloxone
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "0816af83-3c98-4df8-9089-a9c4ea4c677f", "openfda": {"unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["351266"], "spl_set_id": ["e82e2d74-33a8-4894-82f6-788fc0f9feec"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1514-1)", "package_ndc": "71335-1514-1", "marketing_start_date": "20200217"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1514-2)", "package_ndc": "71335-1514-2", "marketing_start_date": "20220921"}], "brand_name": "Buprenorphine HCl and Naloxone HCl", "product_id": "71335-1514_0816af83-3c98-4df8-9089-a9c4ea4c677f", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "71335-1514", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl and Naloxone HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA203136", "marketing_category": "ANDA", "marketing_start_date": "20130222", "listing_expiration_date": "20261231"}